Sanofi-GSK COVID-19 vaccine delayed after disappointing trials

Sanofi and Britain's GlaxoSmithKline said on Friday they will test their potential COVID-19 vaccine further after clinical trials showed an insufficient immune response in older people, delaying its potential launch until the end of next year.

from CBC | Health News https://ift.tt/39WwQNY